Speiser DE - Search Results

1

Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.

Pittet MJ, Speiser DE, Valmori D, Cerottini JC, Romero P. Pittet MJ, et al. Among authors: speiser de. J Immunol. 2000 Feb 1;164(3):1148-52. doi: 10.4049/jimmunol.164.3.1148. J Immunol. 2000. PMID: 10640724

2

Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection.

Speiser DE, Kyburz D, Stübi U, Hengartner H, Zinkernagel RM. Speiser DE, et al. J Immunol. 1992 Aug 1;149(3):972-80. J Immunol. 1992. PMID: 1634779

3

Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.

Kyburz D, Speiser DE, Aebischer T, Hengartner H, Zinkernagel RM. Kyburz D, et al. Among authors: speiser de. J Immunol. 1993 Jun 1;150(11):5051-8. J Immunol. 1993. PMID: 7684417

4

Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.

Bachmann MF, Ohteki T, Faienza KM, Zakarian A, Kägi D, Speiser DE, Ohashi PS. Bachmann MF, et al. Among authors: speiser de. J Immunol. 1997 Nov 1;159(9):4165-70. J Immunol. 1997. PMID: 9379009

5

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.

Speiser DE, Valmori D, Rimoldi D, Pittet MJ, Liénard D, Cerundolo V, MacDonald HR, Cerottini JC, Romero P. Speiser DE, et al. Eur J Immunol. 1999 Jun;29(6):1990-9. doi: 10.1002/(SICI)1521-4141(199906)29:06<1990::AID-IMMU1990>3.0.CO;2-9. Eur J Immunol. 1999. PMID: 10382762 Free article.

6

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.

Valmori D, Pittet MJ, Vonarbourg C, Rimoldi D, Liénard D, Speiser D, Dunbar R, Cerundolo V, Cerottini JC, Romero P. Valmori D, et al. Cancer Res. 1999 Aug 15;59(16):4050-5. Cancer Res. 1999. PMID: 10463606

7

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.

Pittet MJ, Valmori D, Dunbar PR, Speiser DE, Liénard D, Lejeune F, Fleischhauer K, Cerundolo V, Cerottini JC, Romero P. Pittet MJ, et al. Among authors: speiser de. J Exp Med. 1999 Sep 6;190(5):705-15. doi: 10.1084/jem.190.5.705. J Exp Med. 1999. PMID: 10477554 Free PMC article.

8

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

Speiser DE, Pittet MJ, Valmori D, Dunbar R, Rimoldi D, Liénard D, MacDonald HR, Cerottini JC, Cerundolo V, Romero P. Speiser DE, et al. J Exp Med. 1999 Sep 20;190(6):775-82. doi: 10.1084/jem.190.6.775. J Exp Med. 1999. PMID: 10499916 Free PMC article.

9

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Valmori D, Fonteneau JF, Valitutti S, Gervois N, Dunbar R, Liénard D, Rimoldi D, Cerundolo V, Jotereau F, Cerottini JC, Speiser DE, Romero P. Valmori D, et al. Among authors: speiser de. Int Immunol. 1999 Dec;11(12):1971-80. doi: 10.1093/intimm/11.12.1971. Int Immunol. 1999. PMID: 10590263

10

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.

Valmori D, Dutoit V, Liénard D, Lejeune F, Speiser D, Rimoldi D, Cerundolo V, Dietrich PY, Cerottini JC, Romero P. Valmori D, et al. J Immunol. 2000 Jul 1;165(1):533-8. doi: 10.4049/jimmunol.165.1.533. J Immunol. 2000. PMID: 10861093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters